​
Login / Signup
Danna Zheng
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 4
Top Topics
Poor Prognosis
Cancer Therapy
Heat Stress
Renal Cell Carcinoma
Top Venues
Cancer research
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Juan Ji
,
Fen Chen
,
Wenfang He
,
Li Zhao
,
Bo Lin
,
Danna Zheng
,
Li Chen
,
Hongchao He
,
Qiang He
YAP-activated SATB2 is a coactivator of NRF2 that amplifies anti-oxidative capacity and promotes tumor progression in renal cell carcinoma.
Cancer research
(2023)
Juan Ji
,
Fen Chen
,
Wenfang He
,
Li Zhao
,
Bo Lin
,
Danna Zheng
,
Li Chen
,
Hongchao He
,
Qiang He
YAP-Activated SATB2 Is a Coactivator of NRF2 That Amplifies Antioxidative Capacity and Promotes Tumor Progression in Renal Cell Carcinoma.
Cancer research
83 (5) (2023)
Juan Ji
,
Fen Chen
,
Wenfang He
,
Li Zhao
,
Bo Lin
,
Danna Zheng
,
Li Chen
,
Hongchao He
,
Qiang He
YAP-Activated SATB2 Is a Coactivator of NRF2 That Amplifies Antioxidative Capacity and Promotes Tumor Progression in Renal Cell Carcinoma.
Cancer research
83 (5) (2023)
Juan Ji
,
Fen Chen
,
Wenfang He
,
Li Zhao
,
Bo Lin
,
Danna Zheng
,
Li Chen
,
Hongchao He
,
Qiang He
YAP-Activated SATB2 Is a Coactivator of NRF2 That Amplifies Antioxidative Capacity and Promotes Tumor Progression in Renal Cell Carcinoma.
Cancer research
83 (5) (2023)